Related Experiment Video

Updated: Aug 9, 2025

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
08:01

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

1.9K

The Genes-Stemness-Secretome Interplay in Malignant Pleural Mesothelioma: Molecular Dynamics and Clinical Hints

Giulia M Stella1,2, Caterina Marchiò3,4, Elia Bari5

  • 1Department of Internal Medicine and Medical Therapeutics, University of Pavia Medical School, 27100 Pavia, Italy.

International Journal of Molecular Sciences
|February 25, 2023
PubMed

Insights

Malignant pleural mesothelioma (MPM) has a limited mutational landscape, hindering treatment. Novel strategies exploit MPM

Area of Science:

  • Oncology
  • Genetics
  • Environmental Health

Background:

  • Malignant pleural mesothelioma (MPM) exhibits a distinct somatic mutational landscape.
  • Environmental factors significantly influence MPM development and progression.
  • The poor mutational profile of MPM presents challenges for effective therapeutic development.

Purpose of the Study:

  • To explore novel therapeutic strategies for MPM.
  • To investigate the role of genomic events and the tumor microenvironment in MPM progression.
  • To identify actionable targets by understanding the interplay between neoplastic cells, matrix components, and hypoxia.

Main Methods:

  • Genomic analysis to identify MPM-associated genetic signatures.
  • Investigation of the crosstalk between neoplastic cells and the tumor microenvironment.
  • Focus on the role of hypoxia in MPM pathogenesis.
  • Analysis of transcript products and microvesicles as potential biomarkers and therapeutic targets.

Main Results:

  • Genomic events are intrinsically linked to MPM progression.
  • A unique interplay exists between neoplastic cells and matrix components, with hypoxia being a key factor.
  • Transcript products and microvesicles offer insights into pathogenesis.

Conclusions:

  • Exploiting MPM's genetic characteristics and its interaction with the hypoxic microenvironment is a promising therapeutic avenue.
  • Transcript products and microvesicles represent actionable targets for MPM treatment.
  • Understanding the genetic landscape and microenvironment is crucial for developing effective MPM therapies.
Keywords:
geneticsmalignant pleural mesotheliomamicroenvironmenttargeted therapies

More Related Videos

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells11:15

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells

Published on: May 6, 2018

10.3K
Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

9.5K

Related Concept Videos

Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.9K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K